About Modular Genetics
Modular Genetics is a company based in Woburn (United States) founded in 2000. Modular Genetics has raised $7.5 million across 10 funding rounds from investors including Boston University, MassVentures and National Science Foundation. The company has 7 employees as of December 31, 2015. Modular Genetics offers products and services including Automated Gene Engineering System and Engineered Microorganisms. Modular Genetics operates in a competitive market with competitors including Poseida Therapeutics, Senti Biosciences, ADARx Pharmaceuticals, Phoremost and CRISPR Therapeutics, among others.
- Headquarter Woburn, United States
- Employees 7 as on 31 Dec, 2015
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Modular Genetics, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.5 M (USD)
in 10 rounds
-
Latest Funding Round
$100 K (USD), Grant
Aug 23, 2016
-
Investors
Boston University
& 3 more
-
Employee Count
7
as on Dec 31, 2015
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Modular Genetics
Modular Genetics offers a comprehensive portfolio of products and services, including Automated Gene Engineering System and Engineered Microorganisms.
System for developing engineered microorganisms to synthesize chemicals from renewables.
Microbes designed for chemical production using affordable raw materials.
Funding Insights of Modular Genetics
Modular Genetics has successfully raised a total of $7.5M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $100 thousand completed in August 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Modular Genetics
Modular Genetics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston University, MassVentures and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech focused early stage VC firm investing in the US
|
Locked | Locked | Locked | |
|
Venture capital fund backed by the US Government
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for Modular Genetics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Modular Genetics
Investment portfolio details for Modular Genetics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Modular Genetics
Detailed financials for Modular Genetics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Modular Genetics Comparisons
Peer comparison for Modular Genetics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Modular Genetics
Modular Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Poseida Therapeutics, Senti Biosciences, ADARx Pharmaceuticals, Phoremost and CRISPR Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| Locked | Locked | Locked |
Cell-based therapies for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Developer of genetic therapeutic solutions to edit single point mutations on RNA transcripts
|
|
| Locked | Locked | Locked |
Phenotypic screening platform developed to identify drug targets and pathways.
|
|
| Locked | Locked | Locked |
Solutions for genetic diseases are developed using CRISPR-Cas9 genome editing.
|
|
| Locked | Locked | Locked |
Instruments for automated molecular assays are developed using disposable cartridges.
|
Detailed competitors of Modular Genetics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Modular Genetics
Complete news archive for Modular Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Modular Genetics
Modular Genetics was founded in 2000 and raised its 1st funding round 4 years after it was founded.
Modular Genetics is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Modular Genetics is a funded company, having raised a total of $7.5M across 10 funding rounds to date.
As of Dec 31, 2015, the latest employee count at Modular Genetics is 7.
Modular Genetics was founded in 2000 and is based in Woburn, United States. Operations focus on the biotechnology sector, where a platform known as CombiGenix is utilized to synthesize, modify, and recombine genes into novel recombinant DNA molecules. These are integrated with protein design and high-throughput screening processes to enable automated protein evolution. Applications span synthetic biology, industrial biotechnology, and protein therapeutics.
Modular Genetics's top competitors include CRISPR Therapeutics, Senti Biosciences and Poseida Therapeutics.
Modular Genetics offers Automated Gene Engineering System and Engineered Microorganisms.
Modular Genetics has 4 investors. Key investors include Boston University, MassVentures, National Science Foundation, and America’s Seed Fund.